Annual Operating Profit
-$170.96 M
+$32.81 M+16.10%
December 31, 2023
Summary
- As of February 22, 2025, MRSN annual operating income is -$170.96 million, with the most recent change of +$32.81 million (+16.10%) on December 31, 2023.
- During the last 3 years, MRSN annual operating profit has fallen by -$82.85 million (-94.03%).
- MRSN annual operating profit is now -1136.94% below its all-time high of -$13.82 million, reached on December 31, 2016.
Performance
MRSN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$12.07 M
+$13.39 M+52.59%
September 30, 2024
Summary
- As of February 22, 2025, MRSN quarterly operating income is -$12.07 million, with the most recent change of +$13.39 million (+52.59%) on September 30, 2024.
- Over the past year, MRSN quarterly operating profit has increased by +$23.66 million (+66.22%).
- MRSN quarterly operating profit is now -156.27% below its all-time high of $21.45 million, reached on March 31, 2019.
Performance
MRSN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$79.45 M
+$23.66 M+22.94%
September 30, 2024
Summary
- As of February 22, 2025, MRSN TTM operating income is -$79.45 million, with the most recent change of +$23.66 million (+22.94%) on September 30, 2024.
- Over the past year, MRSN TTM operating profit has increased by +$116.40 million (+59.43%).
- MRSN TTM operating profit is now -1382.33% below its all-time high of -$5.36 million, reached on March 31, 2016.
Performance
MRSN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
MRSN Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.1% | +66.2% | +59.4% |
| 3 y3 years | -94.0% | +66.2% | +59.4% |
| 5 y5 years | -160.4% | +66.2% | +59.4% |
MRSN Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.2% | +16.1% | at high | +79.8% | at high | +63.9% |
| 5 y | 5-year | -466.1% | +16.1% | at high | +79.8% | -163.1% | +63.9% |
| alltime | all time | -1136.9% | +16.1% | -156.3% | +79.8% | -1382.3% | +63.9% |
Mersana Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.07 M(-52.6%) | -$79.45 M(-22.9%) |
| Jun 2024 | - | -$25.45 M(+21.2%) | -$103.11 M(-23.1%) |
| Mar 2024 | - | -$21.00 M(+0.3%) | -$134.16 M(-21.5%) |
| Dec 2023 | -$170.96 M(-16.1%) | -$20.93 M(-41.4%) | -$170.96 M(-12.7%) |
| Sep 2023 | - | -$35.73 M(-36.8%) | -$195.85 M(-10.9%) |
| Jun 2023 | - | -$56.50 M(-2.2%) | -$219.77 M(+2.2%) |
| Mar 2023 | - | -$57.80 M(+26.1%) | -$215.02 M(+5.5%) |
| Dec 2022 | -$203.77 M(+20.7%) | -$45.83 M(-23.2%) | -$203.77 M(-1.1%) |
| Sep 2022 | - | -$59.64 M(+15.2%) | -$205.97 M(+7.4%) |
| Jun 2022 | - | -$51.75 M(+11.2%) | -$191.72 M(+6.0%) |
| Mar 2022 | - | -$46.55 M(-3.1%) | -$180.80 M(+7.1%) |
| Dec 2021 | -$168.86 M(+91.6%) | -$48.03 M(+5.8%) | -$168.86 M(+12.9%) |
| Sep 2021 | - | -$45.39 M(+11.2%) | -$149.59 M(+18.1%) |
| Jun 2021 | - | -$40.83 M(+18.0%) | -$126.61 M(+19.9%) |
| Mar 2021 | - | -$34.61 M(+20.3%) | -$105.58 M(+19.8%) |
| Dec 2020 | -$88.11 M | -$28.76 M(+28.3%) | -$88.11 M(+16.0%) |
| Sep 2020 | - | -$22.42 M(+13.3%) | -$75.95 M(+7.2%) |
| Jun 2020 | - | -$19.79 M(+15.4%) | -$70.82 M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$17.14 M(+3.3%) | -$68.79 M(+127.8%) |
| Dec 2019 | -$30.20 M(-54.0%) | -$16.60 M(-4.0%) | -$30.20 M(-17.0%) |
| Sep 2019 | - | -$17.29 M(-2.6%) | -$36.38 M(-0.3%) |
| Jun 2019 | - | -$17.76 M(-182.8%) | -$36.50 M(+16.1%) |
| Mar 2019 | - | $21.45 M(-194.2%) | -$31.44 M(-52.1%) |
| Dec 2018 | -$65.66 M(+65.7%) | -$22.78 M(+30.9%) | -$65.66 M(+14.7%) |
| Sep 2018 | - | -$17.41 M(+37.0%) | -$57.23 M(+19.6%) |
| Jun 2018 | - | -$12.70 M(-0.5%) | -$47.87 M(+8.1%) |
| Mar 2018 | - | -$12.76 M(-11.1%) | -$44.27 M(+11.7%) |
| Dec 2017 | -$39.62 M(+186.6%) | -$14.35 M(+78.3%) | -$39.62 M(+64.7%) |
| Sep 2017 | - | -$8.05 M(-11.6%) | -$24.05 M(+9.9%) |
| Jun 2017 | - | -$9.10 M(+12.2%) | -$21.90 M(+32.1%) |
| Mar 2017 | - | -$8.11 M(-769.9%) | -$16.57 M(+19.9%) |
| Dec 2016 | -$13.82 M(-15.4%) | $1.21 M(-120.6%) | -$13.82 M(-8.1%) |
| Sep 2016 | - | -$5.89 M(+55.8%) | -$15.03 M(+64.4%) |
| Jun 2016 | - | -$3.78 M(-29.4%) | -$9.14 M(+70.6%) |
| Mar 2016 | - | -$5.36 M | -$5.36 M |
| Dec 2015 | -$16.34 M | - | - |
FAQ
- What is Mersana Therapeutics annual operating income?
- What is the all time high annual operating profit for Mersana Therapeutics?
- What is Mersana Therapeutics annual operating profit year-on-year change?
- What is Mersana Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly operating profit year-on-year change?
- What is Mersana Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Mersana Therapeutics?
- What is Mersana Therapeutics TTM operating profit year-on-year change?
What is Mersana Therapeutics annual operating income?
The current annual operating profit of MRSN is -$170.96 M
What is the all time high annual operating profit for Mersana Therapeutics?
Mersana Therapeutics all-time high annual operating income is -$13.82 M
What is Mersana Therapeutics annual operating profit year-on-year change?
Over the past year, MRSN annual operating income has changed by +$32.81 M (+16.10%)
What is Mersana Therapeutics quarterly operating income?
The current quarterly operating profit of MRSN is -$12.07 M
What is the all time high quarterly operating profit for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly operating income is $21.45 M
What is Mersana Therapeutics quarterly operating profit year-on-year change?
Over the past year, MRSN quarterly operating income has changed by +$23.66 M (+66.22%)
What is Mersana Therapeutics TTM operating income?
The current TTM operating profit of MRSN is -$79.45 M
What is the all time high TTM operating profit for Mersana Therapeutics?
Mersana Therapeutics all-time high TTM operating income is -$5.36 M
What is Mersana Therapeutics TTM operating profit year-on-year change?
Over the past year, MRSN TTM operating income has changed by +$116.40 M (+59.43%)